Six big R&D ques­tions for Pfiz­er as sci­ence chief Dol­sten ex­its

The planned ex­it of long­stand­ing Pfiz­er CSO Mikael Dol­sten comes at a piv­otal mo­ment for the huge drug­mak­er. The Covid-19 vac­cine au­ra has ful­ly worn …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.